OptimizeRx Corporation (OPRX) key performance indicators and operating metrics (8 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Net Revenue Retention Rate | 110.00 percent | FY2026-Q1 |
| Non-GAAP Earnings per Share Diluted | 0.14 USD_per_share | FY2026-Q1 |
| Non-GAAP Net Income | 2.7M | FY2026-Q1 |
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization | 3.3M | FY2026-Q1 |
| Average Revenue for Top 20 Pharmaceutical Manufacturers | 2.79M | FY2026-Q1 |
| Revenue per Average Full-Time Employee | 801K | FY2026-Q1 |
| Top 20 Pharmaceutical Manufacturers Share of Total Revenue | 52.00 percent | FY2026-Q1 |
| Gross Margin | 68.00 percent | FY2024-Q4 |
Back to OPRX overview · OPRX earnings · OPRX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.